MML Investors Services’s Verrica Pharmaceuticals VRCA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-2,731	Closed	-$162K	–	2585
2024 Q1	$162K	Sell	2,731 -12,024	-81%	-$664K	﹤0.01%	2378
2023 Q4	$1.08M	Sell	14,755 -1,600	-10%	-$65.7K	0.01%	1307
2023 Q3	$635K	Buy	16,355 +2,200	+16%	+$112K	﹤0.01%	1492
2023 Q2	$817K	Buy	14,155 +2,620	+23%	+$159K	﹤0.01%	1335
2023 Q1	$750K	Buy	11,535 +1,600	+16%	+$96.8K	0.01%	1212
2022 Q4	$273K	Buy	9,935 +940	+10%	+$25.1K	﹤0.01%	1840
2022 Q3	$263K	Buy	8,995 +4,605	+105%	+$158K	﹤0.01%	1766
2022 Q2	$84K	Sell	4,390 -1,660	-27%	-$83.4K	﹤0.01%	1983
2022 Q1	$491K	Buy	6,050 +962	+19%	+$79.3K	﹤0.01%	1465
2021 Q4	$466K	Buy	5,088 +600	+13%	+$68K	﹤0.01%	1456
2021 Q3	$561K	Buy	4,488 +1,040	+30%	+$117K	﹤0.01%	1282
2021 Q2	$390K	Buy	3,448 +1,340	+64%	+$162K	﹤0.01%	1467
2021 Q1	$319K	Sell	2,108 -550	-21%	-$76.1K	﹤0.01%	1483
2020 Q4	$306K	Buy	2,658 +1,508	+131%	+$139K	﹤0.01%	1381
2020 Q3	$89K	Buy	+1,150	New	+$94.2K	﹤0.01%	1543